Study of GS3-007a for children with growth hormone deficiency
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is at least 3 years old
- Child has not started puberty (girls or boys)
- Child is shorter than 97% of kids their age and sex
- Child has been diagnosed with growth hormone deficiency
- Child has never taken any growth-promoting medicines
- Child's bone age is at least 6 months behind their actual age
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new growth hormone treatment called GenSci134 for children who have not yet gone through puberty and are not growing because their bodies do not make enough growth hormone. The goal is to see if the medicine helps them grow taller.
This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.
This trial tests an investigational drug called GenSci134 for children with idiopathic short stature (short height with no known cause). It aims to see if the drug can help them grow taller. The study is for children who have not been treated with growth hormones before.
This trial tests a weekly growth hormone injection called PEG-rhGH to see if it helps short children born small for gestational age grow taller. It may be an option if your child has never taken growth hormone before and meets the height and age requirements.
This trial tests a new growth hormone medicine (GB06) for children whose bodies don't make enough growth hormone naturally. The study will see if this treatment helps children grow taller over time.
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
Hear when a new Pediatric Growth Hormone Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.